Letter: histologic disease activity and colorectal neoplasia risk-authors' reply

Affiliations

¹ Department of Gastroenterology, Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpital Saint-Antoine, Paris, France.
² Department of Pathology, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, Paris, France.

Comment

Julien Kirchgesner et al. Aliment Pharmacol Ther. 2023 Jun.

. 2023 Jun;57(12):1481.

doi: 10.1111/apt.17536.

¹ Department of Gastroenterology, Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpital Saint-Antoine, Paris, France.
² Department of Pathology, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, Paris, France.

No abstract available

Comment on

Risk of colorectal neoplasia according to histologic disease activity in patients with inflammatory bowel disease and colonic post-inflammatory polyps.
Wolf T, Lewis A, Beaugerie L, Svrcek M, Kirchgesner J; Saint-Antoine IBD Network. Wolf T, et al. Aliment Pharmacol Ther. 2023 Jun;57(12):1445-1452. doi: 10.1111/apt.17495. Epub 2023 Mar 31. Aliment Pharmacol Ther. 2023. PMID: 37002640
Letter: histologic disease activity and colorectal neoplasia risk.
Chang HC, Gau SY. Chang HC, et al. Aliment Pharmacol Ther. 2023 Jun;57(12):1480. doi: 10.1111/apt.17528. Aliment Pharmacol Ther. 2023. PMID: 37243459 No abstract available.

1. Chang H-C, Gau S-Y. Letter: histologic disease activity and colorectal neoplasia risk. Aliment Pharmacol Ther. 2023;57:1480.
1. Wolf T, Lewis A, Beaugerie L, Svrcek M, Kirchgesner J, Saint-Antoine IBD Network. Risk of colorectal neoplasia according to histologic disease activity in patients with inflammatory bowel disease and colonic post-inflammatory polyps. Aliment Pharmacol Ther. 2023;57:1445-52.
1. Fontbonne A, Currie A, Tounian P, Picot MC, Foulatier O, Nedelcu M, et al. Prevalence of overweight and obesity in France: the 2020 Obepi-Roche study by the “Ligue Contre l'Obésité.”. J Clin Med. 2023;12(3):925. https://doi.org/10.3390/jcm12030925
1. Shelton E, Laharie D, Scott FI, Mamtani R, Lewis JD, Colombel JF, et al. Cancer recurrence following immune-suppressive therapies in patients with immune-mediated diseases: a systematic review and meta-analysis. Gastroenterology. 2016;151(1):97-109.e4. https://doi.org/10.1053/j.gastro.2016.03.037